Sterling Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.48M | Buy |
35,962
+11,375
| +46% | +$785K | 0.04% | 322 |
|
|
2025
Q1 | $1.71M | Buy |
24,587
+6,110
| +33% | +$424K | 0.03% | 411 |
|
|
2024
Q4 | $1.59M | Sell |
18,477
-1,164
| -6% | -$100K | 0.02% | 488 |
|
|
2024
Q3 | $2.34M | Buy |
+19,641
| New | +$2.34M | 0.03% | 346 |
|
|
2019
Q3 | $481K | Buy |
18,626
+452
| +2% | +$11.7K | ﹤0.01% | 760 |
|
|
2019
Q2 | $464K | Sell |
18,174
-248
| -1% | -$6.33K | ﹤0.01% | 765 |
|
|
2019
Q1 | $482K | Sell |
18,422
-4,168
| -18% | -$109K | ﹤0.01% | 753 |
|
|
2018
Q4 | $520K | Buy |
22,590
+228
| +1% | +$5.25K | 0.01% | 736 |
|
|
2018
Q3 | $527K | Buy |
22,362
+50
| +0.2% | +$1.18K | ﹤0.01% | 781 |
|
|
2018
Q2 | $515K | Sell |
22,312
-678
| -3% | -$15.6K | ﹤0.01% | 755 |
|
|
2018
Q1 | $566K | Buy |
22,990
+402
| +2% | +$9.9K | 0.01% | 742 |
|
|
2017
Q4 | $606K | Buy |
22,588
+30
| +0.1% | +$805 | 0.01% | 744 |
|
|
2017
Q3 | $543K | Buy |
22,558
+1,920
| +9% | +$46.2K | 0.01% | 755 |
|
|
2017
Q2 | $443K | Sell |
20,638
-9,436
| -31% | -$203K | ﹤0.01% | 789 |
|
|
2017
Q1 | $515K | Sell |
30,074
-2,748
| -8% | -$47.1K | ﹤0.01% | 788 |
|
|
2016
Q4 | $588K | Sell |
32,822
-47,814
| -59% | -$857K | 0.01% | 753 |
|
|
2016
Q3 | $1.68M | Buy |
80,636
+6,406
| +9% | +$133K | 0.02% | 425 |
|
|
2016
Q2 | $2M | Buy |
74,230
+58,746
| +379% | +$1.58M | 0.02% | 388 |
|
|
2016
Q1 | $420K | Buy |
15,484
+564
| +4% | +$15.3K | ﹤0.01% | 775 |
|
|
2015
Q4 | $433K | Sell |
14,920
-2,316
| -13% | -$67.2K | ﹤0.01% | 801 |
|
|
2015
Q3 | $467K | Buy |
+17,236
| New | +$467K | ﹤0.01% | 773 |
|